LDK378 Versus Chemotherapy in Previously Untreated Patients With ALK Rearranged Non-small Cell Lung Cancer
Clinical trial NCT01828099 · COMPLETED
Trial details
- NCT number
- NCT01828099
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-07-09
- Primary completion
- 2016-06-24
- Enrollment
- 376
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.